Stock Ideas arrow News Letter Reviews arrow Phase 1 Investor Reviews
Rating
Click for Help

Market Watch

After the Dow reached a new high on July 17 of over 14,000, the market has quickly turned bearish. Well, if you’re waiting to see how things shake out , then take a look at a few picks that aren’t dependent on the volatile market.
More...
 

Login Form






Lost Password?
No account yet? Register
Phase 1 Investor Reviews
User Rating: / 3
PoorBest 
Thursday, 05 February 2009
The investment opportunities Rob uncovers aren't for ordinary investors: Folks who wait around for dividends and rely on 401(k)s. It isn't meant for amateurs trying to get a hot tip to pad their Social Security income...
In short, we only publish Rob's research for a very small audience: folks who have the resources to afford it... cash in on it... and might want to stomach the often bumpy ride of biotech – which most people try to avoid.

And that's why we're limiting access to Rob's new Research Report (March 30) to our most expensive and sophisticated advisory service: Phase 1 Investor.

To my knowledge – there's no other investment research service in the world that compares to Phase 1 Investor. It costs more to produce than any other advisory at S&A Research... not just in terms of
money, but in sheer time alone.

To keep up with modern biotech, every month, Rob logs hundreds of air miles, to attend meetings for The American Society of Hematology... The American Society of Clinical Oncology... The Drug Information Association... and many other major meetings of the world's top medical specialists.

In other words: Phase 1 Investor is where we publish our most rigorous research.
In fact, for many months in the beginning... he didn't allow us to advertise Phase 1 Investor at all. Unless you knew about it, there was no real way to get in.

When you join Phase 1 Investor... you'll receive instant access to the transcript along with Rob's full new report: March 30: Biotech's Last Great Blockbuster.

As you can see – we do everything we can to make sure the recommendations in Phase 1 Investor are among the best-performing research we publish.

And that's why Phase 1 Investor is our most expensive research service.
That said, I believe Phase 1 Investor is actually also the best bargain of anything we publish – considering the amount of time... money... and effort that goes into each new recommendation.

Review The Skousen High-Income Alert

I have an urgent message for you...  Today I am offering you the best gift you could get in these topsy-turvy markets... cold-hard cash. I have reserved $200 just for you to take advantage of...
+ Full Story

Stock TPIM featured in BusinessWeek, and Popular Mechanics!

Make sure you add TPIM to your watch list, one of my alerts last week did roughly 400% in just a few days so it's possible these things can move fast!!! TPIM knows that cancer is one of the top...
+ Full Story



The cost for one full year of Phase 1 Investor is $5,000.

But there is some good news. For reasons I'll explain shortly – for a limited time only, you can get Phase 1 Investor for almost 50% off the standard price.

As I said earlier, that's why we publish Phase 1 Investor: to focus on the kinds of opportunities we simply can't recommend to a mainstream audience.
Sign up right now for a trial subscription to Rob Fannon's Phase 1 Investor. You'll have immediate access to Rob's full new report outlining the opportunity I've been telling you about: March 30: Biotech's Last Great Blockbuster.

Then, take the next 3 months to decide if Phase 1 Investor is right for you.
P.S. Remember – your chance to save ALMOST 50% on a full year of Phase 1 Investor will end shortly. After that... this offer expires.
  • We endeavor to decipher analysis of this Teaser/News Letter to distinguish the thoughts of Authors/Editors.

  • Please post your Review/Comments, your rating helps other users gauge the value of an article ...

  • Was this service a Ripoff ? Click Here To Post Your Ripoff Story !


Bookmark and Share



  Reviews (3)
RSS comments
1. Written by James, on 05-02-2009 22:12
"This is fundamental hard-core science. I am delighted with Phase 1 Investor."
2. Written by Mike, on 05-02-2009 22:09
"Phase 1 Investor gives a "behind-the-scenes" look at biotech. I would never have known about any of these companies without it. Keep up the good work."
3. Written by Macro India, on 05-02-2009 22:08
"I am learning more than I expected about biotech, especially opportunities that I would otherwise near hear about. I am very happy with Phase 1 Investor."

Write review Your rating helps people guage value of an article
Name:
E-mail
BBCode:Web AddressEmail AddressBold TextItalic TextUnderlined TextQuoteCodeOpen ListList ItemClose List
Review:

I wish to be contacted by email regarding additional comments
Sorry but! We have to make sure that you are not a bot Please solve this simple math before you submit:
C           AHH      
H 6    6    W C   8A8
U8S   WN2   6GG      
  B    A    6 B   RWU
  P         358      

 
< Prev   Next >